| Dr Doris Dawn Tyler, PHD, RN | |
|
1501 San Pedro Dr Se, Vamc, Bldg. 41, 3a-104, Albuquerque, NM 87108-5153 | |
| (505) 265-1711 | |
| Not Available |
| Full Name | Dr Doris Dawn Tyler |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Administrator |
| Location | 1501 San Pedro Dr Se, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053592329 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA2000X | Registered Nurse - Administrator | R26273 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Doris Dawn Tyler, PHD, RN 1501 San Pedro Dr Se, Vamc, Bldg. 41, 3a-104, Albuquerque, NM 87108-5153 Ph: (505) 265-1711 | Dr Doris Dawn Tyler, PHD, RN 1501 San Pedro Dr Se, Vamc, Bldg. 41, 3a-104, Albuquerque, NM 87108-5153 Ph: (505) 265-1711 |
News Archive
A team of scientists from government, academia and private industry has developed a novel treatment that protects mice from infection with the bacterium that causes tularemia, a highly infectious disease of rodents, sometimes transmitted to people, and also known as rabbit fever. In additional experiments with human immune cells, the treatment also demonstrated protection against three other types of disease-causing bacteria that, like the tularemia bacteria, occur naturally, can be highly virulent, and are considered possible agents of bioterrorism.
The U.S. Food and Drug Administration (FDA) has announced it has cleared for marketing in the U.S. the TephaFLEX Absorbable Suture - the first absorbable polymer suture made from material isolated from bacteria modified by recombinant DNA technology.
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the launch of its industry-leading SmartChip Human microRNA Panel V2 for gene expression profiling on the SmartChip Real-Time PCR System.
BrainsWay Ltd., the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain disorders, today announces that it has received De Novo clearance from the U.S. Food and Drug Administration (FDA) for its deep transcranial magnetic stimulation (Deep TMS) system for the treatment of obsessive-compulsive disorder (OCD) in adults.
› Verified 4 days ago
Cynthia Ann Kirschenman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1408 Windridge Dr Nw, Albuquerque, NM 87120 Phone: 605-929-5032 Fax: 505-291-2102 | |
Rosa Matonti, RN, MSN, CNS, CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1217 1st St Nw, Albuquerque, NM 87102 Phone: 505-681-0178 | |
Ryan Matson, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4806 Constitution Ave Ne, Albuquerque, NM 87110 Phone: 832-656-7173 | |
Pamela Clark, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6400 Uptown Blvd Ne, Ste 360w, Albuquerque, NM 87110 Phone: 505-855-9805 Fax: 505-848-9468 | |
Michelle Treme, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6400 Uptown Blvd Ne, Ste 360w, Albuquerque, NM 87110 Phone: 505-855-9805 Fax: 505-848-9468 | |
Robert William Adams, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4101 Indian School Rd Ne, Albuquerque, NM 87110 Phone: 505-256-6718 Fax: 505-256-6844 | |
Melissa Velasquez, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 933 Bradbury Dr Se, Albuquerque, NM 87106 Phone: 505-272-3120 Fax: 505-272-8060 |